• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-干扰素和γ-干扰素对人胃癌细胞的直接生长抑制活性。

Direct growth suppressive activity of interferon-alpha and -gamma on human gastric cancer cells.

作者信息

Shyu R Y, Su H L, Yu J C, Jiang S Y

机构信息

Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan, Republic of China.

出版信息

J Surg Oncol. 2000 Oct;75(2):122-30. doi: 10.1002/1096-9098(200010)75:2<122::aid-jso9>3.0.co;2-4.

DOI:10.1002/1096-9098(200010)75:2<122::aid-jso9>3.0.co;2-4
PMID:11064392
Abstract

BACKGROUND AND OBJECTIVES

Interferons (IFNs) exhibit anti-tumor activities through either immune modulation or direct anti-tumor effects. We have investigated the activity and mechanisms of IFN-alpha and IFN-gamma on the growth of TSGH9201, TMK-1 and AGS gastric cancer cells in vitro.

METHODS

Activities of IFNs on cell growth were analyzed by measuring total cellular DNA. Effects of IFNs on apoptosis was evaluated by formation of in situ DNA breakage and DNA ladders. Effects of IFNs on cells cycle phase distribution were analyzed using flow cytometry. Levels of Bcl-2 family proteins after treatment with IFNs were analyzed using Western blot.

RESULTS

Both IFN-alpha and IFN-gamma were active in suppressing the growth of TSGH9201 and TMK-1 cells, while AGS cells were resistant to treatment with IFNs. The IC(50)s of IFN-alpha for TSGH9201 and TMK-1 cells were 300 and 500 U/ml, respectively, and the IC(50)s of IFN-gamma were 40 and 2.0 U/ml, respectively. Both IFN-alpha- and IFN-gamma-induced cell cycle arrest in sensitive cells. IFN-gamma also increased cellular apoptosis, demonstrated by increasing in situ DNA damage and DNA fragmentation. IFN-gamma increased BAK protein levels and decreased Bcl-2 and Bcl-X(S) protein levels in TSGH9201 cells.

CONCLUSIONS

IFN-alpha suppressed growth of gastric cancer cells through induction of cell cycle arrest. IFN-gamma suppressed cell growth through induction of both cell cycle arrest and apoptosis. IFN-gamma-mediated apoptosis was associated with the alteration in protein levels of Bcl-2, Bcl-X(S) and BAK.

摘要

背景与目的

干扰素(IFN)通过免疫调节或直接抗肿瘤作用发挥抗肿瘤活性。我们研究了α干扰素和γ干扰素对TSGH9201、TMK-1和AGS胃癌细胞体外生长的活性及机制。

方法

通过测量细胞总DNA分析干扰素对细胞生长的活性。通过原位DNA断裂和DNA梯带的形成评估干扰素对细胞凋亡的影响。使用流式细胞术分析干扰素对细胞周期阶段分布的影响。使用蛋白质印迹法分析干扰素处理后Bcl-2家族蛋白的水平。

结果

α干扰素和γ干扰素均能有效抑制TSGH9201和TMK-1细胞的生长,而AGS细胞对干扰素处理具有抗性。α干扰素对TSGH9201和TMK-1细胞的半数抑制浓度(IC50)分别为300和500 U/ml,γ干扰素的IC50分别为40和2.0 U/ml。α干扰素和γ干扰素均可诱导敏感细胞的细胞周期停滞。γ干扰素还可增加细胞凋亡,表现为原位DNA损伤和DNA片段化增加。γ干扰素可增加TSGH9201细胞中BAK蛋白水平,降低Bcl-2和Bcl-X(S)蛋白水平。

结论

α干扰素通过诱导细胞周期停滞抑制胃癌细胞生长。γ干扰素通过诱导细胞周期停滞和凋亡抑制细胞生长。γ干扰素介导的凋亡与Bcl-2、Bcl-X(S)和BAK蛋白水平的改变有关。

相似文献

1
Direct growth suppressive activity of interferon-alpha and -gamma on human gastric cancer cells.α-干扰素和γ-干扰素对人胃癌细胞的直接生长抑制活性。
J Surg Oncol. 2000 Oct;75(2):122-30. doi: 10.1002/1096-9098(200010)75:2<122::aid-jso9>3.0.co;2-4.
2
IFN-gamma induces apoptosis in HL-60 cells through decreased Bcl-2 and increased Bak expression.γ干扰素通过降低Bcl-2表达和增加Bak表达诱导HL-60细胞凋亡。
J Interferon Cytokine Res. 2008 Feb;28(2):65-72. doi: 10.1089/jir.2007.0025.
3
Flow cytometric analysis of antineoplastic effects of interferon-alpha, beta and gamma labelled with fluorescein isothiocyanate on cultured brain tumors.
J Neurooncol. 1991 Dec;11(3):225-34. doi: 10.1007/BF00165530.
4
Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines.在造血细胞系中,细胞凋亡的诱导和细胞生长的抑制是对α干扰素的独立反应。
Cell Growth Differ. 1997 Mar;8(3):343-52.
5
Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cells.干扰素调节结肠癌细胞中5-氟尿嘧啶活性的生化机制。
Eur J Cancer. 1997 Mar;33(3):471-8. doi: 10.1016/s0959-8049(97)89024-7.
6
Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon- in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines.Fas/APO-1(CD95)介导的细胞凋亡在白细胞介素-6(IL-6)依赖性和IL-6非依赖性的多发性骨髓瘤细胞系中,由γ干扰素和干扰素激活。
Blood. 1998 Oct 15;92(8):2914-23.
7
Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells.全反式维甲酸与干扰素-γ联合使用可上调p27(kip1)并下调CDK2,从而导致细胞周期停滞,进而使人胶质母细胞瘤LN18(PTEN功能正常)和U87MG(PTEN缺陷)细胞发生分化和凋亡。
Cancer Chemother Pharmacol. 2008 Aug;62(3):407-16. doi: 10.1007/s00280-007-0619-0. Epub 2007 Oct 25.
8
Effect of pseudolaric acid B on gastric cancer cells: inhibition of proliferation and induction of apoptosis.土槿皮酸B对胃癌细胞的作用:抑制增殖并诱导凋亡。
World J Gastroenterol. 2005 Dec 28;11(48):7555-9. doi: 10.3748/wjg.v11.i48.7555.
9
Effects of 5-azacytidine and butyrate on differentiation and apoptosis of hepatic cancer cell lines.5-氮杂胞苷和丁酸盐对肝癌细胞系分化和凋亡的影响。
Ann Surg. 1998 Jun;227(6):922-31. doi: 10.1097/00000658-199806000-00016.
10
Anti-proliferation effects of interferon-gamma on gastric cancer cells.γ-干扰素对胃癌细胞的抗增殖作用。
Asian Pac J Cancer Prev. 2013;14(9):5513-8. doi: 10.7314/apjcp.2013.14.9.5513.

引用本文的文献

1
Exploring the protective association between COVID-19 infection and laryngeal cancer: insights from a Mendelian randomization study.探讨 COVID-19 感染与喉癌之间的保护关联:孟德尔随机化研究的启示。
Front Immunol. 2024 Jun 10;15:1380982. doi: 10.3389/fimmu.2024.1380982. eCollection 2024.
2
Therapeutic effect of human iPS-cell-derived myeloid cells expressing IFN-β against peritoneally disseminated cancer in xenograft models.人诱导多能干细胞来源表达 IFN-β 的髓系细胞对异种移植模型腹腔转移瘤的治疗作用。
PLoS One. 2013 Jun 24;8(6):e67567. doi: 10.1371/journal.pone.0067567. Print 2013.
3
Endogenous interferon gamma directly regulates neural precursors in the non-inflammatory brain.
内源性干扰素 γ 直接调节非炎症性大脑中的神经前体细胞。
J Neurosci. 2010 Jul 7;30(27):9038-50. doi: 10.1523/JNEUROSCI.5691-09.2010.